Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
20:09
ECHR rejects Judge Dorin Munteanu’s application because he concealed the compensation proceedings in Moldova
19:53
The Minister of Health inspected the construction site of the Iași Regional Emergency Hospital / The hospital is expected to be able to receive patients in 2029
19:25
Cracked apartment building in Drumul Taberei: The State Inspectorate for Construction found that the building’s load-bearing structure is not affected / Residents have returned to the building
19:07
Israel closed the access points to Hebron and forcibly displaced nearly 500 families in retaliation
19:00
Two people suffered burns after an explosion followed by a fire in a home in Roșiorii de Vede
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
